T0	Limitation 23103 23105	We
T1	Limitation 23883 23891	Although
T2	Limitation 24291 24293	We
T3	LackOfOutcomeMeasurementData 23123 23163	lack of effect on the vasomotor response
T4	OTHER 23994 24133	pharmacokinetic and pharmacodynamic variation between subjects and the effects of concurrent medical therapy are challenging to standardise
T7	LackOfOutcomeMeasurementData 24208 24289	urther measures of platelet function such as platelet aggregation would be useful
T5	ReliabilityOfMeasurement 24313 24441	possibility that more rapid treatment (within the first 24â€…h) and higher doses of etanercept may have produced different results
